H7187 — Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.

H7187 — Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms. · Informed CitizenryH7187 aims to protect Rhode Island residents by prohibiting private health insurance companies from requiring pre-authorization reviews for specific medications used to treat alcohol and opioid use…Open in Informed Citizenry